• 51.1k views

Management of Hyperbilirubinemia in the Newborn Infant

Hyperbilirubinemia is a common condition in newborn infants, and its management is crucial to prevent severe complications such as kernicterus. The American Academy of Pediatrics (AAP) has published guidelines for the management and prevention of hyperbilirubinemia in newborn infants ≥35 weeks’ gestation. Infants with risk factors for hyperbilirubinemia require closer monitoring than infants without risk factors. Determining the presence of these risk factors requires examining the infant, assessing laboratory data, and obtaining a family history of blood disorders or neonatal jaundice. Phototherapy is an effective treatment for hyperbilirubinemia, but the number needed to treat varies widely depending on sex, gestational age, and other factors.

About the Speaker

Dr. Vishal Parmar
 Profile Image

Dr. Vishal Parmar

Consultant Critical Care , Apollo Hospitals, Mumbai

Dr. Vishal Parmar is a trained Pediatrician with extensive experience in General Pediatrics in NewBorn care & adolescent health.

Upcoming Case Discussions

Leave a Comment

Your email address will not be published.

Author Post

authorimage

Impact

+

Talks

+

webinar

+

no.of registrations

One liner about speaker

Why is speaker relevant?

Dr. Vishal Parmar 's Talks on Assimilate

webinar
Dr. Vishal Parmar
  • 17th-October-2023, TIME : 05:00PM - 06:00PM
  • 0

Hyperbilirubinemia is a common condition in newborn infants, and its management is crucial to prevent severe complications such as kernicterus. The American Academy of Pediatrics (AAP) has published guidelines for the management and prevention of hyperbilirubinemia in newborn infants ≥35 weeks’ gestation. Infants with risk factors for hyperbilirubinemia require closer monitoring than infants without risk factors. Determining the presence of these risk factors requires examining the infant, assessing laboratory data, and obtaining a family history of blood disorders or neonatal jaundice. Phototherapy is an effective treatment for hyperbilirubinemia, but the number needed to treat varies widely depending on sex, gestational age, and other factors.

webinar
Dr. Vishal Parmar
  • 17th-October-2023, TIME : 05:00PM - 06:00PM
  • 0

Hyperbilirubinemia is a common condition in newborn infants, and its management is crucial to prevent severe complications such as kernicterus. The American Academy of Pediatrics (AAP) has published guidelines for the management and prevention of hyperbilirubinemia in newborn infants ≥35 weeks’ gestation. Infants with risk factors for hyperbilirubinemia require closer monitoring than infants without risk factors. Determining the presence of these risk factors requires examining the infant, assessing laboratory data, and obtaining a family history of blood disorders or neonatal jaundice. Phototherapy is an effective treatment for hyperbilirubinemia, but the number needed to treat varies widely depending on sex, gestational age, and other factors.

webinar
Dr. Vishal Parmar
  • 17th-October-2023, TIME : 05:00PM - 06:00PM
  • 0

Hyperbilirubinemia is a common condition in newborn infants, and its management is crucial to prevent severe complications such as kernicterus. The American Academy of Pediatrics (AAP) has published guidelines for the management and prevention of hyperbilirubinemia in newborn infants ≥35 weeks’ gestation. Infants with risk factors for hyperbilirubinemia require closer monitoring than infants without risk factors. Determining the presence of these risk factors requires examining the infant, assessing laboratory data, and obtaining a family history of blood disorders or neonatal jaundice. Phototherapy is an effective treatment for hyperbilirubinemia, but the number needed to treat varies widely depending on sex, gestational age, and other factors.